These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 3643768)

  • 1. Complement activity in normal rabbit bronchoalveolar fluid. Description of an inhibitor of C3 activation.
    Giclas PC; King TE; Baker SL; Russo J; Henson PM
    Am Rev Respir Dis; 1987 Feb; 135(2):403-11. PubMed ID: 3643768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reactivity of the complement system.
    Hadding U
    Monogr Allergy; 1977; 12():36-45. PubMed ID: 335218
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new low molecular-weight protein effector of human complement from the venom of the Central Asian cobra Naja naja oxiana].
    Kozlov LV; Soliakov LS; Zinchenko AA
    Bioorg Khim; 1984 Mar; 10(3):323-32. PubMed ID: 6567467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ; Ai R; Ogata RT
    J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
    Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the complement system in the adult respiratory distress syndrome.
    Robbins RA; Russ WD; Rasmussen JK; Clayton MM
    Am Rev Respir Dis; 1987 Mar; 135(3):651-8. PubMed ID: 3826891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5.
    Sandoval A; Ai R; Ostresh JM; Ogata RT
    J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.
    Till GO; Morganroth ML; Kunkel R; Ward PA
    Am J Pathol; 1987 Oct; 129(1):44-53. PubMed ID: 3661679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions.
    Robertson J; Caldwell JR; Castle JR; Waldman RH
    J Immunol; 1976 Sep; 117(3):900-3. PubMed ID: 956659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation and stability of the fifth component of complement (C5) in bronchoalveolar lavage fluids obtained from non-human primates.
    Kolb WP; Kolb LM; Wetsel RA; Rogers WR; Shaw JO
    Am Rev Respir Dis; 1981 Feb; 123(2):226-31. PubMed ID: 7235362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
    Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
    Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of complement in cigarette smoke-induced chemotactic activity of lung fluids.
    Kew RR; Ghebrehiwet B; Janoff A
    Am Rev Respir Dis; 1986 Mar; 133(3):478-81. PubMed ID: 3954255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.
    Hodgetts SI; Grounds MD
    Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.
    Strunk RC; Eidlen DM; Mason RJ
    J Clin Invest; 1988 May; 81(5):1419-26. PubMed ID: 2966814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
    Cunnion KM; Benjamin DK; Hester CG; Frank MM
    J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteolytic activation systems of complement.
    Reid KB; Porter RR
    Annu Rev Biochem; 1981; 50():433-64. PubMed ID: 7023363
    [No Abstract]   [Full Text] [Related]  

  • 18. Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.
    Fearon DT; Austen KF
    N Engl J Med; 1980 Jul; 303(5):259-63. PubMed ID: 6900901
    [No Abstract]   [Full Text] [Related]  

  • 19. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
    Desai U; Dickey B; Varani J; Kreutzer DL
    J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.